Long-acting formulations delivering aripiprazole: beyond single-value characterizations of steady-state pharmacokinetics

Long-acting formulations delivering aripiprazole: beyond single-value characterizations of steady-state pharmacokinetics

Scott A McConnell,1 Dharmik N Desai,1 Sejal P Faldu,1 Marjie L Hard,2 Angela Y Wehr,3 Peter J Weiden,1 Lisa von Moltke3 1Medical Affairs, Alkermes, Inc., Waltham, MA, 2Nuventra Pharma Sciences, Durham, NC, 3Clinical Research, Alkermes, Inc., Waltham, MA, USAThe recent publication by Salzman et al1...

Full description

Saved in:
Bibliographic Details
Main Authors: McConnell SA, Desai DN, Faldu SP, Hard ML, Wehr AY, Weiden PJ, von Moltke L
Format: article
Language:EN
Published: Dove Medical Press 2017
Subjects:
aripiprazole
aripiprazole lauroxil
pharmacokinetics;long-acting injectables
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Online Access:https://doaj.org/article/8036fa34f015403b9c1b841a7c733a17
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/8036fa34f015403b9c1b841a7c733a17

Similar Items